[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Olanzapine Market Insights, Forecast to 2026

June 2020 | 113 pages | ID: GF8FECDCC885EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.
In 2011, the Lilly’s patent protection expired that had undergone tremendous change of the olanzapine industry. More and more manufacturers had entered the industry leading to the fierce competition on the market. The value of sales of global olanzapine tablets dropped sharply in the past few years.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Olanzapine 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Olanzapine 3900 industry.
Based on our recent survey, we have several different scenarios about the Olanzapine 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 191.5 million in 2019. The market size of Olanzapine 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Olanzapine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Olanzapine market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Olanzapine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Olanzapine market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Olanzapine market, covering important regions, viz, North America, Israel, India and China. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Olanzapine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Olanzapine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Olanzapine market.
The following manufacturers are covered in this report:
  • Lilly
  • Teva Pharmaceutical
  • Dr. Reddy's Laboratories
  • Apotex Inc.
  • Mylan Pharmaceuticals
  • Par Pharmaceutical
  • Aurobindo Pharma
  • Torrent Pharmaceuticals
  • Jubilant Lifesciences
  • Sun Pharmaceutical
  • Sandoz
  • Hansoh Pharmaceutical
  • WATSON Pharmaceuticals(Changzhou)
  • Zhejiang Langhua Pharmaceuticals
Olanzapine Breakdown Data by Type
  • Patent Type
  • Generics Type
Olanzapine Breakdown Data by Application
  • Olanzapine Tablets
  • Other Medicine
1 STUDY COVERAGE

1.1 Olanzapine Product Introduction
1.2 Market Segments
1.3 Key Olanzapine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
  1.4.1 Global Olanzapine Market Size Growth Rate by Type
  1.4.2 Patent Type
  1.4.3 Generics Type
1.5 Market by Application
  1.5.1 Global Olanzapine Market Size Growth Rate by Application
  1.5.2 Olanzapine Tablets
  1.5.3 Other Medicine
1.6 Coronavirus Disease 2019 (Covid-19): Olanzapine Industry Impact
  1.6.1 How the Covid-19 is Affecting the Olanzapine Industry
    1.6.1.1 Olanzapine Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Olanzapine Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Olanzapine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Olanzapine Market Size Estimates and Forecasts
  2.1.1 Global Olanzapine Revenue 2015-2026
  2.1.2 Global Olanzapine Sales 2015-2026
2.2 Olanzapine Market Size by Region: 2020 Versus 2026
  2.2.1 Global Olanzapine Retrospective Market Scenario in Sales by Region: 2015-2020
  2.2.2 Global Olanzapine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 GLOBAL OLANZAPINE COMPETITOR LANDSCAPE BY PLAYERS

3.1 Olanzapine Sales by Manufacturers
  3.1.1 Olanzapine Sales by Manufacturers (2015-2020)
  3.1.2 Olanzapine Sales Market Share by Manufacturers (2015-2020)
3.2 Olanzapine Revenue by Manufacturers
  3.2.1 Olanzapine Revenue by Manufacturers (2015-2020)
  3.2.2 Olanzapine Revenue Share by Manufacturers (2015-2020)
  3.2.3 Global Olanzapine Market Concentration Ratio (CR5 and HHI) (2015-2020)
  3.2.4 Global Top 10 and Top 5 Companies by Olanzapine Revenue in 2019
  3.2.5 Global Olanzapine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Olanzapine Price by Manufacturers
3.4 Olanzapine Manufacturing Base Distribution, Product Types
  3.4.1 Olanzapine Manufacturers Manufacturing Base Distribution, Headquarters
  3.4.2 Manufacturers Olanzapine Product Type
  3.4.3 Date of International Manufacturers Enter into Olanzapine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Olanzapine Market Size by Type (2015-2020)
  4.1.1 Global Olanzapine Sales by Type (2015-2020)
  4.1.2 Global Olanzapine Revenue by Type (2015-2020)
  4.1.3 Olanzapine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Olanzapine Market Size Forecast by Type (2021-2026)
  4.2.1 Global Olanzapine Sales Forecast by Type (2021-2026)
  4.2.2 Global Olanzapine Revenue Forecast by Type (2021-2026)
  4.2.3 Olanzapine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Olanzapine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Olanzapine Market Size by Application (2015-2020)
  5.1.1 Global Olanzapine Sales by Application (2015-2020)
  5.1.2 Global Olanzapine Revenue by Application (2015-2020)
  5.1.3 Olanzapine Price by Application (2015-2020)
5.2 Olanzapine Market Size Forecast by Application (2021-2026)
  5.2.1 Global Olanzapine Sales Forecast by Application (2021-2026)
  5.2.2 Global Olanzapine Revenue Forecast by Application (2021-2026)
  5.2.3 Global Olanzapine Price Forecast by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Olanzapine by Country
  6.1.1 North America Olanzapine Sales by Country
  6.1.2 North America Olanzapine Revenue by Country
  6.1.3 U.S.
  6.1.4 Canada
6.2 North America Olanzapine Market Facts & Figures by Type
6.3 North America Olanzapine Market Facts & Figures by Application

7 EUROPE

7.1 Europe Olanzapine by Country
  7.1.1 Europe Olanzapine Sales by Country
  7.1.2 Europe Olanzapine Revenue by Country
  7.1.3 Germany
  7.1.4 France
  7.1.5 U.K.
  7.1.6 Italy
  7.1.7 Russia
7.2 Europe Olanzapine Market Facts & Figures by Type
7.3 Europe Olanzapine Market Facts & Figures by Application

8 ASIA PACIFIC

8.1 Asia Pacific Olanzapine by Region
  8.1.1 Asia Pacific Olanzapine Sales by Region
  8.1.2 Asia Pacific Olanzapine Revenue by Region
  8.1.3 China
  8.1.4 Japan
  8.1.5 South Korea
  8.1.6 India
  8.1.7 Australia
  8.1.8 Taiwan
  8.1.9 Indonesia
  8.1.10 Thailand
  8.1.11 Malaysia
  8.1.12 Philippines
  8.1.13 Vietnam
8.2 Asia Pacific Olanzapine Market Facts & Figures by Type
8.3 Asia Pacific Olanzapine Market Facts & Figures by Application

9 LATIN AMERICA

9.1 Latin America Olanzapine by Country
  9.1.1 Latin America Olanzapine Sales by Country
  9.1.2 Latin America Olanzapine Revenue by Country
  9.1.3 Mexico
  9.1.4 Brazil
  9.1.5 Argentina
9.2 Central & South America Olanzapine Market Facts & Figures by Type
9.3 Central & South America Olanzapine Market Facts & Figures by Application

10 MIDDLE EAST AND AFRICA

10.1 Middle East and Africa Olanzapine by Country
  10.1.1 Middle East and Africa Olanzapine Sales by Country
  10.1.2 Middle East and Africa Olanzapine Revenue by Country
  10.1.3 Turkey
  10.1.4 Saudi Arabia
  10.1.5 UAE
10.2 Middle East and Africa Olanzapine Market Facts & Figures by Type
10.3 Middle East and Africa Olanzapine Market Facts & Figures by Application

11 COMPANY PROFILES

11.1 Lilly
  11.1.1 Lilly Corporation Information
  11.1.2 Lilly Description, Business Overview and Total Revenue
  11.1.3 Lilly Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 Lilly Olanzapine Products Offered
  11.1.5 Lilly Recent Development
11.2 Teva Pharmaceutical
  11.2.1 Teva Pharmaceutical Corporation Information
  11.2.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
  11.2.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  11.2.4 Teva Pharmaceutical Olanzapine Products Offered
  11.2.5 Teva Pharmaceutical Recent Development
11.3 Dr. Reddy's Laboratories
  11.3.1 Dr. Reddy's Laboratories Corporation Information
  11.3.2 Dr. Reddy's Laboratories Description, Business Overview and Total Revenue
  11.3.3 Dr. Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
  11.3.4 Dr. Reddy's Laboratories Olanzapine Products Offered
  11.3.5 Dr. Reddy's Laboratories Recent Development
11.4 Apotex Inc.
  11.4.1 Apotex Inc. Corporation Information
  11.4.2 Apotex Inc. Description, Business Overview and Total Revenue
  11.4.3 Apotex Inc. Sales, Revenue and Gross Margin (2015-2020)
  11.4.4 Apotex Inc. Olanzapine Products Offered
  11.4.5 Apotex Inc. Recent Development
11.5 Mylan Pharmaceuticals
  11.5.1 Mylan Pharmaceuticals Corporation Information
  11.5.2 Mylan Pharmaceuticals Description, Business Overview and Total Revenue
  11.5.3 Mylan Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  11.5.4 Mylan Pharmaceuticals Olanzapine Products Offered
  11.5.5 Mylan Pharmaceuticals Recent Development
11.6 Par Pharmaceutical
  11.6.1 Par Pharmaceutical Corporation Information
  11.6.2 Par Pharmaceutical Description, Business Overview and Total Revenue
  11.6.3 Par Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  11.6.4 Par Pharmaceutical Olanzapine Products Offered
  11.6.5 Par Pharmaceutical Recent Development
11.7 Aurobindo Pharma
  11.7.1 Aurobindo Pharma Corporation Information
  11.7.2 Aurobindo Pharma Description, Business Overview and Total Revenue
  11.7.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
  11.7.4 Aurobindo Pharma Olanzapine Products Offered
  11.7.5 Aurobindo Pharma Recent Development
11.8 Torrent Pharmaceuticals
  11.8.1 Torrent Pharmaceuticals Corporation Information
  11.8.2 Torrent Pharmaceuticals Description, Business Overview and Total Revenue
  11.8.3 Torrent Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  11.8.4 Torrent Pharmaceuticals Olanzapine Products Offered
  11.8.5 Torrent Pharmaceuticals Recent Development
11.9 Jubilant Lifesciences
  11.9.1 Jubilant Lifesciences Corporation Information
  11.9.2 Jubilant Lifesciences Description, Business Overview and Total Revenue
  11.9.3 Jubilant Lifesciences Sales, Revenue and Gross Margin (2015-2020)
  11.9.4 Jubilant Lifesciences Olanzapine Products Offered
  11.9.5 Jubilant Lifesciences Recent Development
11.10 Sun Pharmaceutical
  11.10.1 Sun Pharmaceutical Corporation Information
  11.10.2 Sun Pharmaceutical Description, Business Overview and Total Revenue
  11.10.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  11.10.4 Sun Pharmaceutical Olanzapine Products Offered
  11.10.5 Sun Pharmaceutical Recent Development
11.1 Lilly
  11.1.1 Lilly Corporation Information
  11.1.2 Lilly Description, Business Overview and Total Revenue
  11.1.3 Lilly Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 Lilly Olanzapine Products Offered
  11.1.5 Lilly Recent Development
11.12 Hansoh Pharmaceutical
  11.12.1 Hansoh Pharmaceutical Corporation Information
  11.12.2 Hansoh Pharmaceutical Description, Business Overview and Total Revenue
  11.12.3 Hansoh Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  11.12.4 Hansoh Pharmaceutical Products Offered
  11.12.5 Hansoh Pharmaceutical Recent Development
11.13 WATSON Pharmaceuticals(Changzhou)
  11.13.1 WATSON Pharmaceuticals(Changzhou) Corporation Information
  11.13.2 WATSON Pharmaceuticals(Changzhou) Description, Business Overview and Total Revenue
  11.13.3 WATSON Pharmaceuticals(Changzhou) Sales, Revenue and Gross Margin (2015-2020)
  11.13.4 WATSON Pharmaceuticals(Changzhou) Products Offered
  11.13.5 WATSON Pharmaceuticals(Changzhou) Recent Development
11.14 Zhejiang Langhua Pharmaceuticals
  11.14.1 Zhejiang Langhua Pharmaceuticals Corporation Information
  11.14.2 Zhejiang Langhua Pharmaceuticals Description, Business Overview and Total Revenue
  11.14.3 Zhejiang Langhua Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  11.14.4 Zhejiang Langhua Pharmaceuticals Products Offered
  11.14.5 Zhejiang Langhua Pharmaceuticals Recent Development

12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)

12.1 Olanzapine Market Estimates and Projections by Region
  12.1.1 Global Olanzapine Sales Forecast by Regions 2021-2026
  12.1.2 Global Olanzapine Revenue Forecast by Regions 2021-2026
12.2 North America Olanzapine Market Size Forecast (2021-2026)
  12.2.1 North America: Olanzapine Sales Forecast (2021-2026)
  12.2.2 North America: Olanzapine Revenue Forecast (2021-2026)
  12.2.3 North America: Olanzapine Market Size Forecast by Country (2021-2026)
12.3 Europe Olanzapine Market Size Forecast (2021-2026)
  12.3.1 Europe: Olanzapine Sales Forecast (2021-2026)
  12.3.2 Europe: Olanzapine Revenue Forecast (2021-2026)
  12.3.3 Europe: Olanzapine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Olanzapine Market Size Forecast (2021-2026)
  12.4.1 Asia Pacific: Olanzapine Sales Forecast (2021-2026)
  12.4.2 Asia Pacific: Olanzapine Revenue Forecast (2021-2026)
  12.4.3 Asia Pacific: Olanzapine Market Size Forecast by Region (2021-2026)
12.5 Latin America Olanzapine Market Size Forecast (2021-2026)
  12.5.1 Latin America: Olanzapine Sales Forecast (2021-2026)
  12.5.2 Latin America: Olanzapine Revenue Forecast (2021-2026)
  12.5.3 Latin America: Olanzapine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Olanzapine Market Size Forecast (2021-2026)
  12.6.1 Middle East and Africa: Olanzapine Sales Forecast (2021-2026)
  12.6.2 Middle East and Africa: Olanzapine Revenue Forecast (2021-2026)
  12.6.3 Middle East and Africa: Olanzapine Market Size Forecast by Country (2021-2026)

13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Olanzapine Players (Opinion Leaders)

14 VALUE CHAIN AND SALES CHANNELS ANALYSIS

14.1 Value Chain Analysis
14.2 Olanzapine Customers
14.3 Sales Channels Analysis
  14.3.1 Sales Channels
  14.3.2 Distributors

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details

LIST OF TABLES

Table 1. Olanzapine Market Segments
Table 2. Ranking of Global Top Olanzapine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Olanzapine Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million)
Table 4. Major Manufacturers of Patent Type
Table 5. Major Manufacturers of Generics Type
Table 6. COVID-19 Impact Global Market: (Four Olanzapine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Olanzapine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Olanzapine Players to Combat Covid-19 Impact
Table 11. Global Olanzapine Market Size Growth Rate by Application 2020-2026 (Kg)
Table 12. Global Olanzapine Market Size by Region (Kg) & (US$ Million): 2020 VS 2026
Table 13. Global Olanzapine Sales by Regions 2015-2020 (Kg)
Table 14. Global Olanzapine Sales Market Share by Regions (2015-2020)
Table 15. Global Olanzapine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Olanzapine Sales by Manufacturers (2015-2020) (Kg)
Table 17. Global Olanzapine Sales Share by Manufacturers (2015-2020)
Table 18. Global Olanzapine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Olanzapine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Olanzapine as of 2019)
Table 20. Olanzapine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Olanzapine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Olanzapine Price (2015-2020) (USD/Kg)
Table 23. Olanzapine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Olanzapine Product Type
Table 25. Date of International Manufacturers Enter into Olanzapine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Olanzapine Sales by Type (2015-2020) (Kg)
Table 28. Global Olanzapine Sales Share by Type (2015-2020)
Table 29. Global Olanzapine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Olanzapine Revenue Share by Type (2015-2020)
Table 31. Olanzapine Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 32. Global Olanzapine Sales by Application (2015-2020) (Kg)
Table 33. Global Olanzapine Sales Share by Application (2015-2020)
Table 34. North America Olanzapine Sales by Country (2015-2020) (Kg)
Table 35. North America Olanzapine Sales Market Share by Country (2015-2020)
Table 36. North America Olanzapine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Olanzapine Revenue Market Share by Country (2015-2020)
Table 38. North America Olanzapine Sales by Type (2015-2020) (Kg)
Table 39. North America Olanzapine Sales Market Share by Type (2015-2020)
Table 40. North America Olanzapine Sales by Application (2015-2020) (Kg)
Table 41. North America Olanzapine Sales Market Share by Application (2015-2020)
Table 42. Europe Olanzapine Sales by Country (2015-2020) (Kg)
Table 43. Europe Olanzapine Sales Market Share by Country (2015-2020)
Table 44. Europe Olanzapine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Olanzapine Revenue Market Share by Country (2015-2020)
Table 46. Europe Olanzapine Sales by Type (2015-2020) (Kg)
Table 47. Europe Olanzapine Sales Market Share by Type (2015-2020)
Table 48. Europe Olanzapine Sales by Application (2015-2020) (Kg)
Table 49. Europe Olanzapine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Olanzapine Sales by Region (2015-2020) (Kg)
Table 51. Asia Pacific Olanzapine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Olanzapine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Olanzapine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Olanzapine Sales by Type (2015-2020) (Kg)
Table 55. Asia Pacific Olanzapine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Olanzapine Sales by Application (2015-2020) (Kg)
Table 57. Asia Pacific Olanzapine Sales Market Share by Application (2015-2020)
Table 58. Latin America Olanzapine Sales by Country (2015-2020) (Kg)
Table 59. Latin America Olanzapine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Olanzapine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Olanzapine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Olanzapine Sales by Type (2015-2020) (Kg)
Table 63. Latin America Olanzapine Sales Market Share by Type (2015-2020)
Table 64. Latin America Olanzapine Sales by Application (2015-2020) (Kg)
Table 65. Latin America Olanzapine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Olanzapine Sales by Country (2015-2020) (Kg)
Table 67. Middle East and Africa Olanzapine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Olanzapine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Olanzapine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Olanzapine Sales by Type (2015-2020) (Kg)
Table 71. Middle East and Africa Olanzapine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Olanzapine Sales by Application (2015-2020) (Kg)
Table 73. Middle East and Africa Olanzapine Sales Market Share by Application (2015-2020)
Table 74. Lilly Corporation Information
Table 75. Lilly Description and Major Businesses
Table 76. Lilly Olanzapine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. Lilly Product
Table 78. Lilly Recent Development
Table 79. Teva Pharmaceutical Corporation Information
Table 80. Teva Pharmaceutical Description and Major Businesses
Table 81. Teva Pharmaceutical Olanzapine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Teva Pharmaceutical Product
Table 83. Teva Pharmaceutical Recent Development
Table 84. Dr. Reddy's Laboratories Corporation Information
Table 85. Dr. Reddy's Laboratories Description and Major Businesses
Table 86. Dr. Reddy's Laboratories Olanzapine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. Dr. Reddy's Laboratories Product
Table 88. Dr. Reddy's Laboratories Recent Development
Table 89. Apotex Inc. Corporation Information
Table 90. Apotex Inc. Description and Major Businesses
Table 91. Apotex Inc. Olanzapine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Apotex Inc. Product
Table 93. Apotex Inc. Recent Development
Table 94. Mylan Pharmaceuticals Corporation Information
Table 95. Mylan Pharmaceuticals Description and Major Businesses
Table 96. Mylan Pharmaceuticals Olanzapine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 97. Mylan Pharmaceuticals Product
Table 98. Mylan Pharmaceuticals Recent Development
Table 99. Par Pharmaceutical Corporation Information
Table 100. Par Pharmaceutical Description and Major Businesses
Table 101. Par Pharmaceutical Olanzapine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 102. Par Pharmaceutical Product
Table 103. Par Pharmaceutical Recent Development
Table 104. Aurobindo Pharma Corporation Information
Table 105. Aurobindo Pharma Description and Major Businesses
Table 106. Aurobindo Pharma Olanzapine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 107. Aurobindo Pharma Product
Table 108. Aurobindo Pharma Recent Development
Table 109. Torrent Pharmaceuticals Corporation Information
Table 110. Torrent Pharmaceuticals Description and Major Businesses
Table 111. Torrent Pharmaceuticals Olanzapine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Torrent Pharmaceuticals Product
Table 113. Torrent Pharmaceuticals Recent Development
Table 114. Jubilant Lifesciences Corporation Information
Table 115. Jubilant Lifesciences Description and Major Businesses
Table 116. Jubilant Lifesciences Olanzapine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Jubilant Lifesciences Product
Table 118. Jubilant Lifesciences Recent Development
Table 119. Sun Pharmaceutical Corporation Information
Table 120. Sun Pharmaceutical Description and Major Businesses
Table 121. Sun Pharmaceutical Olanzapine Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Sun Pharmaceutical Product
Table 123. Sun Pharmaceutical Recent Development
Table 124. Sandoz Corporation Information
Table 125. Sandoz Description and Major Businesses
Table 126. Sandoz Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 127. Sandoz Product
Table 128. Sandoz Recent Development
Table 129. Hansoh Pharmaceutical Corporation Information
Table 130. Hansoh Pharmaceutical Description and Major Businesses
Table 131. Hansoh Pharmaceutical Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 132. Hansoh Pharmaceutical Product
Table 133. Hansoh Pharmaceutical Recent Development
Table 134. WATSON Pharmaceuticals(Changzhou) Corporation Information
Table 135. WATSON Pharmaceuticals(Changzhou) Description and Major Businesses
Table 136. WATSON Pharmaceuticals(Changzhou) Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 137. WATSON Pharmaceuticals(Changzhou) Product
Table 138. WATSON Pharmaceuticals(Changzhou) Recent Development
Table 139. Zhejiang Langhua Pharmaceuticals Corporation Information
Table 140. Zhejiang Langhua Pharmaceuticals Description and Major Businesses
Table 141. Zhejiang Langhua Pharmaceuticals Olanzapine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 142. Zhejiang Langhua Pharmaceuticals Product
Table 143. Zhejiang Langhua Pharmaceuticals Recent Development
Table 144. Global Olanzapine Sales Forecast by Regions (2021-2026) (Kg)
Table 145. Global Olanzapine Sales Market Share Forecast by Regions (2021-2026)
Table 146. Global Olanzapine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 147. Global Olanzapine Revenue Market Share Forecast by Regions (2021-2026)
Table 148. North America: Olanzapine Sales Forecast by Country (2021-2026) (Kg)
Table 149. North America: Olanzapine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Europe: Olanzapine Sales Forecast by Country (2021-2026) (Kg)
Table 151. Europe: Olanzapine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Asia Pacific: Olanzapine Sales Forecast by Region (2021-2026) (Kg)
Table 153. Asia Pacific: Olanzapine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 154. Latin America: Olanzapine Sales Forecast by Country (2021-2026) (Kg)
Table 155. Latin America: Olanzapine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Middle East and Africa: Olanzapine Sales Forecast by Country (2021-2026) (Kg)
Table 157. Middle East and Africa: Olanzapine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 159. Key Challenges
Table 160. Market Risks
Table 161. Main Points Interviewed from Key Olanzapine Players
Table 162. Olanzapine Customers List
Table 163. Olanzapine Distributors List
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Olanzapine Product Picture
Figure 2. Global Olanzapine Sales Market Share by Type in 2020 & 2026
Figure 3. Patent Type Product Picture
Figure 4. Generics Type Product Picture
Figure 5. Global Olanzapine Sales Market Share by Application in 2020 & 2026
Figure 6. Olanzapine Tablets
Figure 7. Other Medicine
Figure 8. Olanzapine Report Years Considered
Figure 9. Global Olanzapine Market Size 2015-2026 (US$ Million)
Figure 10. Global Olanzapine Sales 2015-2026 (Kg)
Figure 11. Global Olanzapine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Olanzapine Sales Market Share by Region (2015-2020)
Figure 13. Global Olanzapine Sales Market Share by Region in 2019
Figure 14. Global Olanzapine Revenue Market Share by Region (2015-2020)
Figure 15. Global Olanzapine Revenue Market Share by Region in 2019
Figure 16. Global Olanzapine Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Olanzapine Revenue in 2019
Figure 18. Olanzapine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Olanzapine Sales Market Share by Type (2015-2020)
Figure 20. Global Olanzapine Sales Market Share by Type in 2019
Figure 21. Global Olanzapine Revenue Market Share by Type (2015-2020)
Figure 22. Global Olanzapine Revenue Market Share by Type in 2019
Figure 23. Global Olanzapine Market Share by Price Range (2015-2020)
Figure 24. Global Olanzapine Sales Market Share by Application (2015-2020)
Figure 25. Global Olanzapine Sales Market Share by Application in 2019
Figure 26. Global Olanzapine Revenue Market Share by Application (2015-2020)
Figure 27. Global Olanzapine Revenue Market Share by Application in 2019
Figure 28. North America Olanzapine Sales Growth Rate 2015-2020 (Kg)
Figure 29. North America Olanzapine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Olanzapine Sales Market Share by Country in 2019
Figure 31. North America Olanzapine Revenue Market Share by Country in 2019
Figure 32. U.S. Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 33. U.S. Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 35. Canada Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Olanzapine Market Share by Type in 2019
Figure 37. North America Olanzapine Market Share by Application in 2019
Figure 38. Europe Olanzapine Sales Growth Rate 2015-2020 (Kg)
Figure 39. Europe Olanzapine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Olanzapine Sales Market Share by Country in 2019
Figure 41. Europe Olanzapine Revenue Market Share by Country in 2019
Figure 42. Germany Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 43. Germany Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 45. France Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 47. U.K. Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 49. Italy Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 51. Russia Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Olanzapine Market Share by Type in 2019
Figure 53. Europe Olanzapine Market Share by Application in 2019
Figure 54. Asia Pacific Olanzapine Sales Growth Rate 2015-2020 (Kg)
Figure 55. Asia Pacific Olanzapine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Olanzapine Sales Market Share by Region in 2019
Figure 57. Asia Pacific Olanzapine Revenue Market Share by Region in 2019
Figure 58. China Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 59. China Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 61. Japan Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 63. South Korea Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 65. India Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 67. Australia Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 69. Taiwan Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 71. Indonesia Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 73. Thailand Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 75. Malaysia Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 77. Philippines Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 79. Vietnam Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Olanzapine Market Share by Type in 2019
Figure 81. Asia Pacific Olanzapine Market Share by Application in 2019
Figure 82. Latin America Olanzapine Sales Growth Rate 2015-2020 (Kg)
Figure 83. Latin America Olanzapine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Olanzapine Sales Market Share by Country in 2019
Figure 85. Latin America Olanzapine Revenue Market Share by Country in 2019
Figure 86. Mexico Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 87. Mexico Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 89. Brazil Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 91. Argentina Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Olanzapine Market Share by Type in 2019
Figure 93. Latin America Olanzapine Market Share by Application in 2019
Figure 94. Middle East and Africa Olanzapine Sales Growth Rate 2015-2020 (Kg)
Figure 95. Middle East and Africa Olanzapine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Olanzapine Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Olanzapine Revenue Market Share by Country in 2019
Figure 98. Turkey Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 99. Turkey Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 101. Saudi Arabia Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Olanzapine Sales Growth Rate (2015-2020) (Kg)
Figure 103. UAE Olanzapine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Olanzapine Market Share by Type in 2019
Figure 105. Middle East and Africa Olanzapine Market Share by Application in 2019
Figure 106. Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Dr. Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Apotex Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Mylan Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Par Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Torrent Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Jubilant Lifesciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Hansoh Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. WATSON Pharmaceuticals(Changzhou) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Zhejiang Langhua Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. North America Olanzapine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 121. North America Olanzapine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Europe Olanzapine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 123. Europe Olanzapine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Asia Pacific Olanzapine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 125. Asia Pacific Olanzapine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Latin America Olanzapine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 127. Latin America Olanzapine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Middle East and Africa Olanzapine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 129. Middle East and Africa Olanzapine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Porter's Five Forces Analysis
Figure 131. Channels of Distribution
Figure 132. Distributors Profiles
Figure 133. Bottom-up and Top-down Approaches for This Report
Figure 134. Data Triangulation
Figure 135. Key Executives Interviewed


More Publications